Is Cabotegravir a Gender-Neutral PrEP Medication?

Video

Alex Rinehart, PhD, explains how cabotegravir is a gender-neutral pre-exposure prophylaxis medication.

Alex Rinehart, PhD, Director, Global Prevention Strategy, ViiV Healthcare, explains studies that are underway involving how effective the PrEP medication cabotegravir is in men who have sex with men as well as transgendered women. Dr. Rinehart stresses that he and his team are trying to study efficacy in all relevant key populations affected by HIV.

Related Videos
A panel of 4 experts on HIV
A panel of 4 experts on HIV
Shauna Applin, ARNP, an expert on HIV
Shauna Applin, ARNP, an expert on HIV
A panel of 4 experts on HIV
A panel of 4 experts on HIV
© 2024 MJH Life Sciences

All rights reserved.